CADL

Candel Therapeutics Inc

$10.75

0.06 (0.58%) Today

0.45 (4.37%) After-hours

— up— down

Market Cap

$755M+103.6%

Revenue (TTM)

$0

$0

Net Income (TTM)

$-71,628,752

$-71,628,752

EPS (TTM)

-0.98

-0.98

Shares Out

73.27M

73.27M

Open

$10.44

$10.44

Previous Close

$10.36

$10.36

Day Range

$10.28 – $11.35

$10.28 – $11.35

52-Week Range

$4.35 – $11.35

$4.35 – $11.35

Beta

-0.48

-0.48

Earnings Date

Aug 12, 2026

Aug 12, 2026

Volume

2.93M

2.93M

Avg Volume

1.91M

1.91M

Analyst Rating

Buy

Buy

Exchange

NASDAQ NMS - GLOBAL MARKET

NASDAQ NMS - GLOBAL MARKET

About CADL

Related

News

Candel Therapeutics Starts Pivotal Phase 3 AURORA Study Of Aglatimagene Besadenovec Plus Valacyclovir In Combination With Continued Pembrolizumab In Participants With Metastatic Non-Squamous Non-Small Cell Lung Cancer

Benzinga · 17h ago